Investors have been climbing on board and the stock has been going nowhere but up…
The Washington Post says, “this industry could be bigger than the NFL by 2020.” And in case you’re wondering that’s $35 BILLION compared to $10 BILLION for the NFL.
Are your juices flowing yet? They should be. HERE’S WHY…
While there’s oodles of cash driving this industry this biotech stock is one that is going to bolt!
In the last month the SPDR S&P Biotech ETF (XBI) is off more-than 5% – while Vitality Biopharma VBIO HAS NEARLY DOUBLED IN PRICE.
We’re featuring one of the hottest biotech stocks out there that’s grabbing investors’ attention, Vitality Biopharma VBIO and for no small reason. Read on…
Vitality Biopharma VBIO is developing proprietary cannabinoid pharmaceuticals for treatment of serious neurological and inflammatory disorders, such as inflammatory bowel disease and multiple sclerosis.
Source :- yahoonews
The Washington Post says, “this industry could be bigger than the NFL by 2020.” And in case you’re wondering that’s $35 BILLION compared to $10 BILLION for the NFL.
Are your juices flowing yet? They should be. HERE’S WHY…
While there’s oodles of cash driving this industry this biotech stock is one that is going to bolt!
In the last month the SPDR S&P Biotech ETF (XBI) is off more-than 5% – while Vitality Biopharma VBIO HAS NEARLY DOUBLED IN PRICE.
We’re featuring one of the hottest biotech stocks out there that’s grabbing investors’ attention, Vitality Biopharma VBIO and for no small reason. Read on…
Vitality Biopharma VBIO is developing proprietary cannabinoid pharmaceuticals for treatment of serious neurological and inflammatory disorders, such as inflammatory bowel disease and multiple sclerosis.
Source :- yahoonews
Comments
Post a Comment